Precision Neuroscience announced the closing of a $250 million Series D funding round for its brain-computer interface technology. The investment round was led by Bill Ackman’s Pershing Square, the Ackman Oxman Institute, and an undisclosed life sciences fund. This latest funding values the New York-based company at just over $1 billion, according to The New York Times. The influx of capital highlights growing interest in advanced neurotechnology solutions.
Back
